As of Feb 24
| -0.14 / -2.14%|
The 5 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 6.86, with a high estimate of 14.00 and a low estimate of 5.00. The median estimate represents a +7.25% increase from the last price of 6.40.
The current consensus among 7 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.